Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2018

01.08.2018 | Commentary

The role and strategy of ISoP in global pharmacovigilance

verfasst von: Sten Olsson, Mira Harrison-Woolrych

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Applying the WHO definition of pharmacovigilance, the International Society of Pharmacovigilance, (ISoP) is concerned with all aspects of medicine safety. The safety of patients exposed to medicines depends on a wide variety of factors, where the understanding of each factor is associated with its own professional competence and skillset. For pharmacovigilance systems to work efficiently, a broad understanding of the necessary contribution of each of the different scientific competence areas and professional skills is required. ISoP is an independent, not-for-profit international professional organization, concerned with the best interest of patients exposed to pharmaceutical interventions in all healthcare systems in the world. ISoP offers an open platform for professionals from around the world with different expertise and skillsets, to network and exchange information and knowledge in a friendly environment. The society wishes to become a stronger global voice, speaking up in favour of patient safety and to be at the frontline of the global patient safety movement.
Literatur
1.
Zurück zum Zitat Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the french way. Lancet. 1985;2(8463):1056–8.CrossRef Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the french way. Lancet. 1985;2(8463):1056–8.CrossRef
4.
Zurück zum Zitat Velo G. Ecopharmacovigilance. In: Edwards IR, Lindquist M, editors. Pharmacovigilance, critique and ways forward. Berlin: Springer; 2017. p. 195–205.CrossRef Velo G. Ecopharmacovigilance. In: Edwards IR, Lindquist M, editors. Pharmacovigilance, critique and ways forward. Berlin: Springer; 2017. p. 195–205.CrossRef
5.
Zurück zum Zitat Olsson S, Wong ICK, Delumeau J-C, Harrison-Woolrych M. The new phase of ISoP. Drug Saf. 2017;40:841–4.CrossRef Olsson S, Wong ICK, Delumeau J-C, Harrison-Woolrych M. The new phase of ISoP. Drug Saf. 2017;40:841–4.CrossRef
7.
Zurück zum Zitat McCarthy D, Bahri P, Barnres J, Delumeau J-C, Edwards B, Harrison-Woolrych M. An update on ISoP special interest groups (SIGs). Drug Saf. 2018;41:1–6.CrossRef McCarthy D, Bahri P, Barnres J, Delumeau J-C, Edwards B, Harrison-Woolrych M. An update on ISoP special interest groups (SIGs). Drug Saf. 2018;41:1–6.CrossRef
8.
Zurück zum Zitat Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG. The ISoP CommSIG for improving medicinal product risk communication: a new special interest group of the International Society of Pharmacovigilance. Drug Saf. 2015;38:621–7 (on behalf of the ISoP CommSIG).CrossRef Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG. The ISoP CommSIG for improving medicinal product risk communication: a new special interest group of the International Society of Pharmacovigilance. Drug Saf. 2015;38:621–7 (on behalf of the ISoP CommSIG).CrossRef
10.
Zurück zum Zitat Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37:743–59.CrossRef Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37:743–59.CrossRef
Metadaten
Titel
The role and strategy of ISoP in global pharmacovigilance
verfasst von
Sten Olsson
Mira Harrison-Woolrych
Publikationsdatum
01.08.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0708-7

Weitere Artikel der Ausgabe 4/2018

International Journal of Clinical Pharmacy 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.